| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |